Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 313

1.

Recurrent intraventricular thrombus six months after ST-elevation myocardial infarction in a diabetic man: a case report.

Lacalzada J, Marí B, Izquierdo MM, Sánchez-Grande A, de la Rosa A, Laynez I.

BMC Res Notes. 2013 Sep 2;6:348. doi: 10.1186/1756-0500-6-348.

2.

Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy.

Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H.

Am J Cardiol. 2010 Nov 1;106(9):1197-200. doi: 10.1016/j.amjcard.2010.06.043.

PMID:
21029812
3.

[Acute myocardial infarction after discontinuing aspirin two years after implantation of a drug-eluting coronary stent].

Krüth P, Heer T, Senges J, Zeymer U.

Dtsch Med Wochenschr. 2007 Feb 2;132(5):201-4. German.

PMID:
17252362
4.

Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).

Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Räber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB; DESERT Investigators..

JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017.

5.
6.

Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim CJ, Yoon JH, Chung WS, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry Investigators..

Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791.

7.

Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.

De Luca G, Sauro R, Capasso M, Lanzillo T, Manganelli F, Carbone G, Lanni F, Pagliuca MR, Palmieri V, Serino V, Rosato G, Suryapranata H, Di Lorenzo E.

Diab Vasc Dis Res. 2015 Sep;12(5):306-14. doi: 10.1177/1479164115592252.

PMID:
26150193
9.

Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction.

Mano Y, Koide K, Sukegawa H, Kodaira M, Ohki T.

Heart Vessels. 2016 Jan;31(1):118-23. doi: 10.1007/s00380-014-0562-z.

PMID:
25081096
10.

Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?

Ibrahim K, Hass N, Kolschmann S, Strasser RH, Braun-Dullaeus RC.

Clin Res Cardiol. 2008 Nov;97(11):797-800. doi: 10.1007/s00392-008-0679-0.

PMID:
18663507
11.

Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.

Le May MR, Acharya S, Wells GA, Burwash I, Chong AY, So DY, Glover CA, Froeschl MP, Hibbert B, Marquis JF, Dick A, Blondeau M, Bernick J, Labinaz M.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):155-62. doi: 10.1016/j.jcin.2014.07.018.

12.
13.
14.

Late stent thrombosis of a second-generation drug- eluting stent.

Karjalainen PP, Nammas W, Ylitalo A.

J Invasive Cardiol. 2012 Oct;24(10):E225-7.

15.

Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.

Al-Dehneh A, Virk H, Alkhouri Y, Hamdan A, Bikkina M.

Tex Heart Inst J. 2010;37(3):343-6. Review.

16.

Simultaneous Two-Vessel Subacute Stent Thrombosis Caused by Clopidogrel Resistance from CYP2C19 Polymorphism.

Afzal A, Patel B, Patel N, Sattur S, Patel V.

Case Rep Med. 2016;2016:2312078. doi: 10.1155/2016/2312078.

17.

The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.

Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW.

JACC Cardiovasc Interv. 2014 Jan;7(1):64-71. doi: 10.1016/j.jcin.2013.09.006.

18.

Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids.

Ilhan E, Demirci D, Güvenç TS, Calık AN.

Turk Kardiyol Dern Ars. 2010 Jun;38(4):275-8.

19.

Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).

Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.

JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.

Items per page

Supplemental Content

Support Center